Two Sigma Securities’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Two Sigma Securities's BIIB Position: Q2 2026 in Review
Two Sigma Securities sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1,335 shares — an estimated $245K sold.
Two Sigma Securities first reported a position in BIIB in Q4 2015 and held it in 23 quarters. The position peaked at $2.49M in Q3 2018. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Two Sigma Securities reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
- Two Sigma Securities sold 1,335 Biogen shares in Q2 2026, an estimated $245K.
- Two Sigma Securities first reported a position in Biogen in Q4 2015 and held it in 23 quarters.
- Two Sigma Securities's Biogen position peaked at $2.49M in Q3 2018.
- 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.